<DOC>
	<DOCNO>NCT00694863</DOCNO>
	<brief_summary>The purpose study determine whether treatment long-acting synthetic adrenocorticotropic hormone treatment patient idiopathic membranous nephropathy high renal failure .</brief_summary>
	<brief_title>Treatment With Synthetic ACTH High Risk Patients With Membranous Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , Membranous</mesh_term>
	<mesh_term>Adrenocorticotropin zinc</mesh_term>
	<mesh_term>Cosyntropin</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>Biopsyproven idiopathic membranous nephropathy . Nephrotic syndrome : proteinuria &gt; 3.5 g/day serum albumine &lt; 30 g/l Normal mildly impair renal function ( eGFR &gt; 60 ml/min , MDRD formula ) High risk renal failure : beta2microglobulin excretion &gt; 500 ng/min Relative contraindication cyclophosphamide treatment : fertility wish ( future ) family expand high age ( &gt; 60 year ) former cyclophosphamide treatment intolerance cyclophosphamide Clinical , biochemical histological sign underlie systemic disease Any infectious disease ( include latent tuberculosis and/or latent amoebiasis ) Active gastric duodenal ulcer Pregnancy , lactation , inadequate contraceptive Clinical sign renal vein thrombosis Asthma /or allergic condition hypersensitivity reaction Allergic reaction synthetic ACTH past</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>high risk ESRD</keyword>
	<keyword>immunosuppressive treatment</keyword>
	<keyword>membranous nephropathy</keyword>
	<keyword>ACTH</keyword>
</DOC>